8th DIA Annual Conference in Japan for Asian New Drug Development

Featured

Want to learn more about 8th DIA Annual Conference in Japan for Asian New Drug Development? You've come to the right site!

Hidetoshi Shuto Senior Fellow, Corporate Technology Sector
Nitto Denko Corporation, Japan
Ari Fujishiro Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Division
Daiichi Sankyo Co., Ltd., Japan
Tomohisa Hayakawa, PhD Corporate Officer; Head of BD & PM
EPS International Holdings Co., Ltd., Japan
Shii Man, MD, PhD
Otsuka Beijing Research Institute, China
Koichi Miyazaki, PhD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan
Yasuto Otsubo Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Minsoo Park
KCGI, Korea, Republic of
Kihito Takahashi Partner
Mirasense Partners, Japan
Akio Uemura, PhD Senior Advisor
AU Consulting, Co., Japan
Yoshiaki Uyama, PhD, RPh Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jisin Yang, MD Global Clinical Program Director, Japan R&D
CSL Behring K.K., Japan